Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Class A 688505
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 8.06
- Day Range
- CNY 7.85–8.08
- 52-Week Range
- CNY 6.24–10.71
- Bid/Ask
- CNY 7.87 / CNY 7.88
- Market Cap
- CNY 8.21 Bil
- Volume/Avg
- 2.6 Mil / 3.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 103.26
- Price/Sales
- 10.46
- Dividend Yield (Trailing)
- 0.89%
- Dividend Yield (Forward)
- 0.89%
- Total Yield
- 0.89%
Company Profile
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in the research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 948
- Website
- http://www.fd-zj.com
Comparables
Valuation
|
Metric
|
688505
|
688553
|
688192
|
|---|---|---|---|
Price/Earnings (Normalized) | 103.26 | 134.81 | — |
Price/Book Value | 3.48 | 1.61 | 24.33 |
Price/Sales | 10.46 | 6.57 | 96.76 |
Price/Cash Flow | — | 45.00 | — |
Price/Earnings
688505
688553
688192
Financial Strength
|
Metric
|
688505
|
688553
|
688192
|
|---|---|---|---|
Quick Ratio | 3.91 | 3.36 | 1.59 |
Current Ratio | 4.05 | 3.63 | 1.80 |
Interest Coverage | 39.35 | 5.52 | −100.52 |
Quick Ratio
688505
688553
688192
Profitability
|
Metric
|
688505
|
688553
|
688192
|
|---|---|---|---|
Return on Assets (Normalized) | 3.88% | 1.88% | −66.38% |
Return on Equity (Normalized) | 4.83% | 2.29% | −99.78% |
Return on Invested Capital (Normalized) | 4.52% | 1.42% | −78.11% |
Return on Assets
688505
688553
688192
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Shmwkbydkd | Hvtp | $77.1 Bil | |
MKKGY
| Merck KGaA ADR | Phrwjxjbtd | Xztwxn | $72.9 Bil | |
HLN
| Haleon PLC ADR | Kpstctsq | Crlqc | $37.5 Bil | |
VTRS
| Viatris Inc | Fwnjqhtwy | Bnm | $13.3 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Qynqcvw | Kgyg | $11.7 Bil | |
CTLT
| Catalent Inc | Wpmpcczv | Fmwcfh | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Clxmlqwh | Nxvr | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Qylxtcbq | Ttn | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Cmtbdnwz | Mgdlfk | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Grzbklvq | Csdn | $3.0 Bil |